Financial Year |
March 31 2023 |
Monetary Funds |
2,946,511,639.28 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
6,588,658,056.77 |
Advances to Suppliers |
13,465,143.58 |
Other Receivables |
104,750,385.79 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
294,710,265.04 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
62,620,837.02 |
Total Current Assets |
10,124,855,451.83 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
199,931,095.02 |
Investment Properties |
32,114,160.20 |
Fixed Assetes |
1,711,686,538.17 |
Under-construction Projects |
193,418,688.60 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
149,647,665.69 |
R&D expenses |
-- |
Goodwill |
32,679,884.07 |
Long-Term Deferred and Prepaid Expenses |
257,004,391.46 |
Deferred Income Tax Assets |
111,340,562.41 |
Other Non-Current Assets |
105,050,524.23 |
Sub-Total of Non-Current Assets |
3,284,514,467.51 |
Total Assets |
13,409,369,919.34 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
2,749,070,254.25 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
487,621,327.14 |
Taxes Payable |
189,067,832.36 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
205,057,170.73 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
240,467,798.57 |
Other Current Liabilities |
2,028,372.66 |
Sub-Total of Current Liabilities |
3,976,246,934.17 |
Long-term Loans |
139,950,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
62,720,005.48 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
411,955,968.95 |
Total Liabilities |
4,388,202,903.12 |
Paid-In Capital(Or Share Stock) |
467,303,775.00 |
Capital Surplus |
1,536,368,112.67 |
Surplus Reserve |
233,569,387.50 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
6,545,656,876.89 |
Minority Stockholder's Interest |
235,096,469.19 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,786,070,547.03 |
Owner's Equity(Stockholder's Equity) |
9,021,167,016.22 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
13,409,369,919.34 |